UY39856A - Inhibidores peptídicos del receptor de interleucina-23 - Google Patents
Inhibidores peptídicos del receptor de interleucina-23Info
- Publication number
- UY39856A UY39856A UY0001039856A UY39856A UY39856A UY 39856 A UY39856 A UY 39856A UY 0001039856 A UY0001039856 A UY 0001039856A UY 39856 A UY39856 A UY 39856A UY 39856 A UY39856 A UY 39856A
- Authority
- UY
- Uruguay
- Prior art keywords
- interleukin
- receptor
- peptide inhibitors
- disorders
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221806P | 2021-07-14 | 2021-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39856A true UY39856A (es) | 2023-02-28 |
Family
ID=84920532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039856A UY39856A (es) | 2021-07-14 | 2022-07-14 | Inhibidores peptídicos del receptor de interleucina-23 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240409598A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4370531A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024525780A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240034222A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117999274A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022310354A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3226539A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024000762A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202332683A (cg-RX-API-DMAC7.html) |
| UY (1) | UY39856A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023288028A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| CA2949215C (en) | 2014-05-16 | 2023-03-14 | Protagonist Therapeutics, Inc. | .alpha.4.beta.7 integrin thioether peptide antagonists |
| SG10201810154WA (en) | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| WO2018022937A1 (en) | 2016-07-27 | 2018-02-01 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases |
| WO2019157268A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| MX2022008740A (es) | 2020-01-15 | 2022-09-23 | Janssen Biotech Inc | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| KR20240034224A (ko) | 2021-07-14 | 2024-03-13 | 얀센 바이오테크 인코포레이티드 | 인터류킨-23 수용체의 지질화된 펩티드 억제제 |
| EP4652179A1 (en) * | 2023-01-16 | 2025-11-26 | Janssen Pharmaceutica NV | Lipidated peptide inhibitors of interleukin-23 receptor |
| EP4652180A2 (en) * | 2023-01-16 | 2025-11-26 | Janssen Pharmaceutica NV | Peptide inhibitors of interleukin-23 receptor |
| TW202440615A (zh) * | 2023-01-16 | 2024-10-16 | 比利時商健生藥品公司 | 介白素-23受體之肽抑制劑 |
| KR20250139359A (ko) * | 2023-01-31 | 2025-09-23 | 얀센 파마슈티카 엔브이 | 인터류킨-23 수용체의 결정질 펩티드 억제제의 제조 방법 |
| AU2024233524A1 (en) * | 2023-03-03 | 2025-10-16 | Janssen Pharmaceutica Nv | Interleukin-23 receptor antagonist peptides for use in the treatment of psoriasis |
| EP4471048A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| EP4471049A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| CN121794283A (zh) | 2023-09-08 | 2026-04-03 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| CN121909205A (zh) | 2023-09-08 | 2026-04-21 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2026026816A1 (zh) * | 2024-07-30 | 2026-02-05 | 西藏海思科制药有限公司 | 白介素-23受体的肽抑制剂及其用途 |
| WO2026041110A1 (zh) * | 2024-08-22 | 2026-02-26 | 上海瀚辰星泰医药科技有限公司 | 一种多肽化合物及其应用 |
| WO2026046292A1 (zh) * | 2024-08-28 | 2026-03-05 | 西藏海思科制药有限公司 | 白介素-23受体的肽抑制剂的药物组合物及其制备方法和用途 |
| WO2026138829A1 (zh) * | 2024-12-23 | 2026-07-02 | 上海医药集团股份有限公司 | 多肽抑制剂及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9605027B2 (en) * | 2011-06-14 | 2017-03-28 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| SG10201810154WA (en) * | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| HK1257747A1 (zh) * | 2015-07-15 | 2019-10-25 | Protagonist Therapeutics Inc. | 白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途 |
| US10787490B2 (en) * | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP2020505352A (ja) * | 2017-01-18 | 2020-02-20 | プロタゴニスト セラピューティクス, インコーポレイテッド | インターロイキン−23受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| CA3104418A1 (en) * | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2020311395A1 (en) * | 2019-07-10 | 2022-02-03 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| SMT202500254T1 (it) * | 2020-01-15 | 2025-09-12 | Janssen Biotech Inc | Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie |
-
2022
- 2022-07-14 CA CA3226539A patent/CA3226539A1/en active Pending
- 2022-07-14 UY UY0001039856A patent/UY39856A/es unknown
- 2022-07-14 JP JP2024501976A patent/JP2024525780A/ja active Pending
- 2022-07-14 EP EP22842905.6A patent/EP4370531A4/en active Pending
- 2022-07-14 AU AU2022310354A patent/AU2022310354A1/en not_active Abandoned
- 2022-07-14 CN CN202280061973.9A patent/CN117999274A/zh active Pending
- 2022-07-14 TW TW111126555A patent/TW202332683A/zh unknown
- 2022-07-14 WO PCT/US2022/037221 patent/WO2023288028A2/en not_active Ceased
- 2022-07-14 KR KR1020247004772A patent/KR20240034222A/ko active Pending
- 2022-07-14 US US18/579,062 patent/US20240409598A1/en active Pending
- 2022-07-14 MX MX2024000762A patent/MX2024000762A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024525780A (ja) | 2024-07-12 |
| MX2024000762A (es) | 2024-04-18 |
| WO2023288028A2 (en) | 2023-01-19 |
| US20240409598A1 (en) | 2024-12-12 |
| EP4370531A2 (en) | 2024-05-22 |
| TW202332683A (zh) | 2023-08-16 |
| CA3226539A1 (en) | 2023-01-19 |
| WO2023288028A3 (en) | 2023-02-23 |
| EP4370531A4 (en) | 2025-09-03 |
| CN117999274A (zh) | 2024-05-07 |
| AU2022310354A1 (en) | 2024-02-29 |
| KR20240034222A (ko) | 2024-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY39858A (es) | Inhibidores peptídicos bicíclicos del receptor de interleucina-23 | |
| MX2024000762A (es) | Inhibidores peptidicos del receptor de interleucina-23. | |
| CO2023007172A2 (es) | Composiciones de inhibidores peptídicos del receptor de interleucina-23 | |
| UY39857A (es) | Inhibidores peptídicos lipidados del receptor de interleucina-23 | |
| ECSP22063238A (es) | Inhibidores de péptidos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias | |
| MX2022008740A (es) | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. | |
| CO2024005925A2 (es) | Moléculas pequeñas para el tratamiento del cáncer | |
| AR119389A1 (es) | Inhibidores de péptidos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias | |
| MX2024009477A (es) | Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de estos | |
| TR201816176T4 (tr) | Histon deasetilaz 6 inhibitörleri olarak yeni bileşikler ve bunu içeren farmasötik bileşimler. | |
| AR101871A1 (es) | Composiciones de glicoconjugado inmunogénico / terapéutico y sus usos | |
| JOP20230089A1 (ar) | مثبطات إنترليوكين-17 | |
| MX2025008274A (es) | Formulaciones de inhibidores peptidicos lipidados del receptor de interleucina-23 | |
| MX2025010360A (es) | Peptidos antagonistas del receptor de interleucina-23 para usar en el tratamiento de la psoriasis | |
| WO2024155547A3 (en) | Peptide inhibitors of interleukin-23 receptor | |
| CO2025010249A2 (es) | Inhibidores peptídicos del receptor de interleucina-23 | |
| DOP2025000151A (es) | Inhibidores peptídicos del receptor de interleucina-23 | |
| UY40134A (es) | Motor de presión negativa | |
| JOP20230150A1 (ar) | صيغ ببتيد علاجية | |
| EA202191511A1 (ru) | Составы на основе аналога пептида оксинтомодулина | |
| MX2021007417A (es) | Formas cristalinas de un inhibidor del receptor 4 activado por proteasa (par4). | |
| EA202092756A1 (ru) | Конденсированные бициклические соединения для применения в качестве ингибиторов убиквитин-специфической пептидазы 30 |